Lifestyle Behavior Change
Cardiovascular diseases cause 31% of all global deaths. In recent studies, and including available data from the current COVID-19 pandemic, it has been shown that patients with cardiovascular co-morbidities such as hypertension, diabetes, and other cardiovascular diseases are at a significantly higher risk of fatality. In addition, behavioral risk factors including unhealthy diet, physical inactivity, tobacco use, and harmful use of alcohol can cause the onset of cardiovascular disease as well as disease progression.
This year, we are looking for companies that are developing behavior change solutions that empower people to reduce their risk of cardio-metabolic conditions (such as hypertension, chronic artery disease, etc.) by changing lifestyle habits.
Track: Open to both Growth and Advanced
Patient Monitoring
Considering the current COVID-19 pandemic, patients worldwide living with chronic cardiovascular disease will not only be at risk for severe complications, many will not be able to receive timely treatment through office visits or physical therapy, and can put caretakers at risk. To improve patient care and reduce risk of death, patients and care teams can be empowered by patient-focused monitoring solutions that can track progression of the patients’ conditions and effectiveness of treatment as well as support early diagnosis of related conditions.
We are looking for solutions which would allow a convenient and effortless way of longitudinally monitoring patients inside and outside the traditional healthcare setting, especially people with or at risk for cardiometabolic and renal diseases especially hypertension, coronary artery disease (CAD), congestive health failure (CHF) and chronic kidney disease (CKD).
Track: Open to both Growth and Advanced
Biomarkers and Algorithms
Digital tools allow for a streamlined way of generating, collecting and analyzing data that can be used to explain or predict health-related patient outcomes, giving rise to new biomarkers. These biomarkers could play a valuable role in facilitating risk and event prediction, timely diagnosis and improved treatment of cardiovascular diseases.
We are looking for companies developing novel biomarkers (digital, biological or in combination) and algorithms to predict the risk, progression or start of acute events in cardiovascular and renal diseases especially for hypertension, coronary artery disease (CAD), congestive heart failure (CHF) and chronic kidney disease (CKD).
Track: Open to both Growth and Advanced
Risk-stratification and Decision Support
Predictive tools are opening new ways of assessing disease risk and providing informative, actionable healthcare advice. These tools can bring together and synthesize information from various sources to provide relevant insights, empowering physicians and healthcare providers to make decisions for achieving better healthcare outcomes for patients.
We are looking for solutions that can predict risks for cardiovascular patients (such as risk of disease progression, risk of readmissions, etc.) and provide insights to better manage their condition throughout their disease journey. We are especially looking for solutions for hypertension, coronary artery disease (CAD), congestive heart failure (CHF) and chronic kidney disease (CKD).
Track: Open to both Growth and Advanced